Longwood Capital Partners

Latest statistics and disclosures from Acuta Capital Partners's latest quarterly 13F-HR filing:

Tip: Access up to 7 years of quarterly data

Positions held by Longwood Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for Acuta Capital Partners

Companies in the Acuta Capital Partners portfolio as of the December 2020 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Celldex Therapeutics Com New (CLDX) 7.8 $29M +5% 1.6M 17.52
Sage Therapeutics (SAGE) 6.0 $22M +13% 256k 86.51
Kura Oncology (KURA) 5.7 $21M -34% 638k 32.66
Larimar Therapeutics (LRMR) 5.0 $19M +3% 863k 21.41
Mersana Therapeutics (MRSN) 5.0 $19M +3% 694k 26.61
Compass Pathways Sponsored Ads (CMPS) 4.1 $15M -18% 319k 47.64
Vistagen Therapeutics Com New (VTGN) 4.0 $15M NEW 7.5M 1.94
Athira Pharma (ATHA) 3.7 $14M +8% 393k 34.25
Immunovant (IMVT) 3.6 $13M +13% 284k 46.19
Trillium Therapeutics Com New (TRIL) 3.2 $12M -5% 803k 14.71
Arrowhead Pharmaceuticals (ARWR) 2.9 $11M +36% 139k 76.73
89bio (ETNB) 2.9 $11M +4% 434k 24.37
Syndax Pharmaceuticals (SNDX) 2.8 $10M +93% 466k 22.24
Apellis Pharmaceuticals (APLS) 2.6 $9.6M 167k 57.20

Setup an alert

Longwood Capital Partners will file the next quarterly 13-HR in about 3 months. Would you like to be notified?

Bcls Acquisition Corp Com Cl A 2.6 $9.4M NEW 843k 11.14
Surface Oncology (SURF) 2.5 $9.2M -8% 1000k 9.24
Catalyst Biosciences Com New (CBIO) 2.3 $8.6M -9% 1.4M 6.31
Iveric Bio (ISEE) 2.3 $8.4M +51% 1.2M 6.91
Fulcrum Therapeutics (FULC) 2.2 $8.0M +78% 683k 11.71
Replimune Group (REPL) 2.2 $7.9M NEW 208k 38.15
Iovance Biotherapeutics (IOVA) 2.1 $7.6M -47% 165k 46.40
Concert Pharmaceuticals I equity (CNCE) 1.8 $6.8M +79% 538k 12.64
Altimmune Com New (ALT) 1.8 $6.5M -15% 579k 11.28
Avidity Biosciences Ord (RNA) 1.7 $6.3M +4% 246k 25.52
Jiya Acquisition Corp Com Cl A 1.6 $5.8M NEW 563k 10.30
Stoke Therapeutics (STOK) 1.6 $5.7M NEW 93k 61.94
Verastem (VSTM) 1.4 $5.1M 2.4M 2.13
Health Sciences Acq Corp 2 Ord Shs (HSAQ) 1.4 $5.0M 393k 12.81
Avadel Pharmaceuticals Sponsored Adr (AVDL) 1.3 $4.7M 705k 6.68
Curis Com New (CRIS) 1.2 $4.3M NEW 530k 8.19
Biohaven Pharmaceutical Holding Call Option (BHVN) 1.2 $4.3M NEW 50k 85.72
Praxis Precision Medicines I 1.1 $4.2M NEW 76k 55.02
Rapt Therapeutics (RAPT) 1.1 $4.1M -12% 210k 19.75
Relmada Therapeutics (RLMD) 1.0 $3.8M -56% 120k 32.07
C4 Therapeutics Com Stk 1.0 $3.6M NEW 110k 33.13
Madrigal Pharmaceuticals (MDGL) 1.0 $3.6M NEW 33k 111.17
Clearside Biomedical (CLSD) 0.9 $3.4M +103% 1.3M 2.74
Cymabay Therapeutics (CBAY) 0.5 $1.9M -56% 330k 5.74
Oncorus 0.5 $1.7M NEW 54k 32.34
Aldeyra Therapeutics (ALDX) 0.4 $1.3M -88% 193k 6.86
Xenon Pharmaceuticals (XENE) 0.3 $1.2M -73% 80k 15.38
Cyclacel Pharmaceuticals (CYCC) 0.3 $1.2M NEW 150k 7.81
Rocket Pharmaceuticals (RCKT) 0.3 $1.1M NEW 20k 54.85
Pmv Pharmaceuticals (PMVP) 0.3 $923k NEW 15k 61.53
Wave Life Sciences SHS (WVE) 0.2 $846k 108k 7.87
4d Molecular Therapeutics In 0.2 $829k NEW 20k 41.45
Annexon (ANNX) 0.2 $626k -77% 25k 25.04
Karuna Therapeutics Ord (KRTX) 0.1 $508k -62% 5.0k 101.60
Axsome Therapeutics (AXSM) 0.1 $489k -73% 6.0k 81.50
Panacea Acquisition Corp *w Exp 07/07/202 (PANA.WS) 0.1 $299k NEW 93k 3.20
Novavax Com New (NVAX) 0.1 $279k NEW 2.5k 111.60

Past Filings by Acuta Capital Partners

SEC 13F filings are viewable for Acuta Capital Partners going back to 2014

View all past filings